Clinical Trial

VALIDATION OF FUSION CEMEP SCORE FOR OMITTING SYSTEMATIC PROSTATE BIOPSY

Study acronym: FUSION-CEMEP
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to prospectively validate the Fusion CEMEP score to assess the safety and efficacy of omitting systematic prostate biopsy in patients undergoing multiparametric magnetic resonance imaging-targeted biopsy. The main objective is to determine if target-only biopsy guided by the score is sufficient for clinically significant prostate cancer detection while reducing overtreatment and unnecessary cores.
Trial Details
NCT Number NCT07753356
Lead Sponsor Marcelo Ruben Oliva
Conditions Prostate Cancer, Prostatic Neoplasms/Diagnosis
Enrollment 150 participants
Start Date 2026-08-15
Primary Completion 2027-12-20 (estimated)
Study Completion 2029-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-07